CXCL12 and thyroid gland carcinoma: Furthermore, by integrating analyses, we also directly verified the CXCL12 dominance in the HT-derived stromal cells, rather than cells from normal tissue or HT-free thyroid cancer samples (Supplemental Figure 12, C and D).